Transaction in Own Shares

Summary by AI BETAClose X

RTW Biotech Opportunities Ltd announced on November 21, 2025, that it repurchased 100,000 of its Ordinary Shares on November 20, 2025, at a price of $1.87 per share. Following this transaction, the Company's issued Ordinary Share capital stands at 345,967,440, with 18,943,791 shares held in treasury, resulting in a total of 327,023,649 voting rights. This buyback was conducted under shareholder authority granted in June 2025, with the intention to hold repurchased shares in treasury and without paying a premium to net asset value.

Disclaimer*

UK 100

Latest directors dealings